Gallbladder cancer overview: Difference between revisions
No edit summary |
|||
| Line 10: | Line 10: | ||
==Overview== | ==Overview== | ||
[[Gallbladder]] [[cancer]] may be classified according to [[histology]] findings into various subtypes and are as follows [[Adenocarcinoma]], [[Papillary]] [[adenocarcinoma]], [[Mucinous]] adenocarcinoma, [[Signet ring cell carcinoma]], [[Adenosquamous carcinoma]], [[Squamous cell carcinoma]], [[Neuroendocrine]] [[carcinoma]], [[Small cell carcinoma]], [[undifferentiated]] carcinoma, spindle cell undifferentiated carcinoma, giant cell undifferentiated [[carcinoma]].It is understood that GBC is the result of persistent [[irritation]] of the gallbladder [[mucosa]] over a period of years which predispose to [[malignant]] transformation or act as an enhancer for [[Carcinogen|carcinogenic]] exposure.The primary mechanism involves [[cholelithiasis]] and resultant [[cholecystitis]] and appears to be the driving force in most areas of the arena.Chronically [[Inflammation|inflamed]] [[gallbladder]] may additionally express both pyloric gland and [[intestinal]] [[metaplasia]].But, fluke-infested gallbladders more commonly shows intestinal metaplasia and [[P53 (protein)|p53]] [[Mutation|mutations]] than sporadic [[Gallbladder cancer|gallbladder cancers]].[[Dysplasia|Dysplastic]] lesions have [[molecular]] [[genetic]] proof that supports progression towards [[CIS]].There are also histologic and molecular differences in GBCs related to anomalous pancreaticobiliary duct junction and in the ones related to [[gallstones]], Providing further proof that two different pathogenetic pathways are involved.Less than 3% of early gallbladder carcinomas have [[adenomatous]] remnants, indicating this mechanism has less importance within the [[carcinogenic]] pathway.Around 80 t0 95% of [[biliary tract]] [[Cancer|cancers]] are gallbladder cancers.[[Epidemiology|Epidemiological]] research has recognized striking geographic and [[Ethnic group|ethnic]] difference. An excessive incidence in American Indians and Southeast Asia, but pretty low in the America and the arena.[[Gallstones]], [[Porcelain gallbladder]], [[Gallbladder polyp|Gallbladder polyps]], [[Primary sclerosing cholangitis]] (PSC) , chronic infection, congenital biliary cysts, pancreaticobiliary maljunction (PBM).There is no [[Screening test|screening]] recommended for [[gallbladder cancer]]. According to the National Comprehensive Cancer Network (NCCN) guidelines, gallbladder cancer may be diagnosed as an incidental finding in patients who undergo [[laparoscopic]] [[cholecystectomy]].[[Gallbladder cancer (patient information)|Gallbladder cancer]] must be differentiated from [[hepatitis]], [[gallstones]], [[cholecystitis]], [[peptic ulcer]], [[pancreatic cancer]] and [[pancreatitis]].Depending on the extent of the tumor at the time of [[diagnosis]], the prognosis may vary. However, the prognosis is generally regarded as poor.Most tumors are [[Adenocarcinoma|adenocarcinomas]], with a small percent being [[squamous cell]] carcinomas. The cancer commonly spreads to the [[liver]], [[pancreas]], [[stomach]] and [[duodenum]]. The survival rate depends on the extent of cancer at the time of diagnosis with [[gallbladder cancer]] and early detection is key for good [[prognosis]].According to the AJCC, there are 4 stages of [[gallbladder cancer]] based on the tumor [[Spread of the cancer|spread]].[[Symptom|Symptoms]] of gallbladder cancer include [[jaundice]], [[pain]], [[fever]], [[burping]] and [[weight loss]].Laboratory findings consistent with the diagnosis of gallbladder [[cancer]] include abnormal [[liver function tests]] and elevated [[CA 19-9]] and [[CEA]] levels.On [[Abdomen|abdominal]] [[Computed tomography|CT]] scan, [[gallbladder cancer]] appears as large [[heterogeneous]] [[mass]] with areas of [[necrosis]].[[Palliative therapy]] in [[gallbladder cancer]]<nowiki/>involves [[percutaneous]] transhepatic radiologic [[catheter]] bypass or endoscopically placed [[Stent|stents]], standard external-beam [[radiation]] therapy, [[palliative]] surgery or standard [[chemotherapy]].Research suggests that lifestyle factors such as changes in [[Diet (nutrition)|diet]], [[exercise]], and maintenance of weight can influence the likelihood of an individual developing [[gallbladder cancer]].Research suggests that lifestyle factors such as changes in [[Diet (nutrition)|diet]], [[exercise]], and maintenance of weight can influence the likelihood of an individual developing [[gallbladder cancer]] | |||
== Historical Perspective == | |||
In 1777 Maxmillan de Stol described the [[gallbladder cancer]] and since studies have established in the identification of the [[disease]] and ineffective treatment of this disease.[[Gallbladder cancer]](GBC) are often clinically [[asymptomatic]] and an surprising finding at [[incision]], most commonly detected incidentally on [[Histology|histological]] examination.GBC is characterised by local [[invasion]], intensive regional [[lymphoid tissue]] [[metastasis]] and distant [[metastases]]. In general, GBC is that the most aggressive of the [[biliary]] cancers with the shortest median survival period. | |||
==Classification== | ==Classification== | ||
[[Gallbladder | [[Gallbladder cancer]] may be classified according to [[World Health Organization|WHO]] into various subtypes like [[adenocarcinoma]], [[papillary]] adenocarcinoma, [[mucinous]] adenocarcinoma, [[signet ring cell carcinoma]], [[adenosquamous carcinoma]], [[squamous cell]] [[carcinoma]], [[neuroendocrine]] carcinoma, [[small cell carcinoma]], [[undifferentiated]] carcinoma, [[spindle cell]] undifferentiated carcinoma, giant cell [[undifferentiated]] carcinoma. | ||
== Pathophysiology == | |||
[[Gallbladder cancer]] usually develops in the setting of chronic [[inflammation]] of the [[gallbladder]].The most common source of [[chronic inflammation]] is [[cholesterol]] [[gallstones]]. The [[gallbladder cancer]] risk increases to 4-5% in the presence [[gallbladder cancer]] (GBC) is the result of 2 or more different [[biological]] pathways based on morphological, [[Genetics|genetic]], and [[molecular]] evidence. [[Metaplasia]] is believed to be one of the pathological reason behind the development of [[gallbladder carcinoma]]. Although the definite relationship between [[metaplasia]] and [[dysplasia]], is not clearly established yet. On [[gross pathology]], [[fibrosis]] and thickening of the gallbladder are characteristic findings of the [[gallbladder cancer]]. On [[microscopic]] histopathological analysis, outer portion is often better differentiated than deeper portion are characteristic findings of [[gallbladder cancer]]. | |||
== Causes == | |||
Definite cause of the [[gallbladder cancer]] is not determined, but several risk factors are involved in this cancer, such as [[Gallstone disease|gallstones]], [[gallbladder]] [[Polyp|polyps]], infections, and [[Primary sclerosing cholangitis]]. | |||
== Epidemiology and Demographics == | |||
Around 80 t0 95% of biliary tract cancers are [[Gallbladder cancer|gallbladder cancers]]. [[Epidemiology|Epidemiological]] research has recognized striking geographic and [[Ethnic group|ethnic]] difference. An excessive incidence in American Indians and Southeast Asia, but pretty low in the America and the arena. | |||
== Risk Factors == | |||
The most potent risk factor in the development of [[Gallbladder cancer|gallbladder carcinoma]] is [[Gallstone disease|gallstones]]. Other risk factors include [[Porcelain gallbladder]], [[Gallbladder polyp|gallbladder polyps]], [[Primary sclerosing cholangitis]], chronic infection, pancreaticobiliary maljunction (PBM) and biliary cysts. | |||
== Screening == | |||
According to the National Comprehensive Cancer Network (NCCN) guidelines, [[gallbladder cancer]] may be diagnosed as an incidental finding in patients who undergo [[laparoscopic]] [[cholecystectomy]]. | |||
== Differential diagnosis == | |||
Gallbladder cancer must be differentiated from hepatocellular carcinoma [[Liver hemangioma|liver hemangioma,]] [[Liver abscess]], [[cirrhosis]], [[Inflammation|inflammatory]] [[Lesion|lesions]], [[Cholangiocarcinoma|cholangiocarcinoma,]] [[Pancreatic carcinoma|pancreatic carcinoma,]] [[Focal nodular hyperplasia]]. | |||
== Natural History, Prognosis, and Complications == | |||
Depending on the extent of the [[tumor]] at the time of diagnosis, the [[prognosis]] may vary. However, the [[prognosis]] is generally regarded as poor. | |||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
Revision as of 00:00, 13 January 2019
| https://https://www.youtube.com/watch?v=WsmW6I0cmBE%7C350}} |
|
Gallbladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gallbladder cancer overview On the Web |
|
American Roentgen Ray Society Images of Gallbladder cancer overview |
|
Risk calculators and risk factors for Gallbladder cancer overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
Gallbladder cancer may be classified according to histology findings into various subtypes and are as follows Adenocarcinoma, Papillary adenocarcinoma, Mucinous adenocarcinoma, Signet ring cell carcinoma, Adenosquamous carcinoma, Squamous cell carcinoma, Neuroendocrine carcinoma, Small cell carcinoma, undifferentiated carcinoma, spindle cell undifferentiated carcinoma, giant cell undifferentiated carcinoma.It is understood that GBC is the result of persistent irritation of the gallbladder mucosa over a period of years which predispose to malignant transformation or act as an enhancer for carcinogenic exposure.The primary mechanism involves cholelithiasis and resultant cholecystitis and appears to be the driving force in most areas of the arena.Chronically inflamed gallbladder may additionally express both pyloric gland and intestinal metaplasia.But, fluke-infested gallbladders more commonly shows intestinal metaplasia and p53 mutations than sporadic gallbladder cancers.Dysplastic lesions have molecular genetic proof that supports progression towards CIS.There are also histologic and molecular differences in GBCs related to anomalous pancreaticobiliary duct junction and in the ones related to gallstones, Providing further proof that two different pathogenetic pathways are involved.Less than 3% of early gallbladder carcinomas have adenomatous remnants, indicating this mechanism has less importance within the carcinogenic pathway.Around 80 t0 95% of biliary tract cancers are gallbladder cancers.Epidemiological research has recognized striking geographic and ethnic difference. An excessive incidence in American Indians and Southeast Asia, but pretty low in the America and the arena.Gallstones, Porcelain gallbladder, Gallbladder polyps, Primary sclerosing cholangitis (PSC) , chronic infection, congenital biliary cysts, pancreaticobiliary maljunction (PBM).There is no screening recommended for gallbladder cancer. According to the National Comprehensive Cancer Network (NCCN) guidelines, gallbladder cancer may be diagnosed as an incidental finding in patients who undergo laparoscopic cholecystectomy.Gallbladder cancer must be differentiated from hepatitis, gallstones, cholecystitis, peptic ulcer, pancreatic cancer and pancreatitis.Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor.Most tumors are adenocarcinomas, with a small percent being squamous cell carcinomas. The cancer commonly spreads to the liver, pancreas, stomach and duodenum. The survival rate depends on the extent of cancer at the time of diagnosis with gallbladder cancer and early detection is key for good prognosis.According to the AJCC, there are 4 stages of gallbladder cancer based on the tumor spread.Symptoms of gallbladder cancer include jaundice, pain, fever, burping and weight loss.Laboratory findings consistent with the diagnosis of gallbladder cancer include abnormal liver function tests and elevated CA 19-9 and CEA levels.On abdominal CT scan, gallbladder cancer appears as large heterogeneous mass with areas of necrosis.Palliative therapy in gallbladder cancerinvolves percutaneous transhepatic radiologic catheter bypass or endoscopically placed stents, standard external-beam radiation therapy, palliative surgery or standard chemotherapy.Research suggests that lifestyle factors such as changes in diet, exercise, and maintenance of weight can influence the likelihood of an individual developing gallbladder cancer.Research suggests that lifestyle factors such as changes in diet, exercise, and maintenance of weight can influence the likelihood of an individual developing gallbladder cancer
Historical Perspective
In 1777 Maxmillan de Stol described the gallbladder cancer and since studies have established in the identification of the disease and ineffective treatment of this disease.Gallbladder cancer(GBC) are often clinically asymptomatic and an surprising finding at incision, most commonly detected incidentally on histological examination.GBC is characterised by local invasion, intensive regional lymphoid tissue metastasis and distant metastases. In general, GBC is that the most aggressive of the biliary cancers with the shortest median survival period.
Classification
Gallbladder cancer may be classified according to WHO into various subtypes like adenocarcinoma, papillary adenocarcinoma, mucinous adenocarcinoma, signet ring cell carcinoma, adenosquamous carcinoma, squamous cell carcinoma, neuroendocrine carcinoma, small cell carcinoma, undifferentiated carcinoma, spindle cell undifferentiated carcinoma, giant cell undifferentiated carcinoma.
Pathophysiology
Gallbladder cancer usually develops in the setting of chronic inflammation of the gallbladder.The most common source of chronic inflammation is cholesterol gallstones. The gallbladder cancer risk increases to 4-5% in the presence gallbladder cancer (GBC) is the result of 2 or more different biological pathways based on morphological, genetic, and molecular evidence. Metaplasia is believed to be one of the pathological reason behind the development of gallbladder carcinoma. Although the definite relationship between metaplasia and dysplasia, is not clearly established yet. On gross pathology, fibrosis and thickening of the gallbladder are characteristic findings of the gallbladder cancer. On microscopic histopathological analysis, outer portion is often better differentiated than deeper portion are characteristic findings of gallbladder cancer.
Causes
Definite cause of the gallbladder cancer is not determined, but several risk factors are involved in this cancer, such as gallstones, gallbladder polyps, infections, and Primary sclerosing cholangitis.
Epidemiology and Demographics
Around 80 t0 95% of biliary tract cancers are gallbladder cancers. Epidemiological research has recognized striking geographic and ethnic difference. An excessive incidence in American Indians and Southeast Asia, but pretty low in the America and the arena.
Risk Factors
The most potent risk factor in the development of gallbladder carcinoma is gallstones. Other risk factors include Porcelain gallbladder, gallbladder polyps, Primary sclerosing cholangitis, chronic infection, pancreaticobiliary maljunction (PBM) and biliary cysts.
Screening
According to the National Comprehensive Cancer Network (NCCN) guidelines, gallbladder cancer may be diagnosed as an incidental finding in patients who undergo laparoscopic cholecystectomy.
Differential diagnosis
Gallbladder cancer must be differentiated from hepatocellular carcinoma liver hemangioma, Liver abscess, cirrhosis, inflammatory lesions, cholangiocarcinoma, pancreatic carcinoma, Focal nodular hyperplasia.
Natural History, Prognosis, and Complications
Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor.